I. Schipper

发表

The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.

W. Hop, B. Fauser, I. Schipper, 1998, The Journal of clinical endocrinology and metabolism.

Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood.

I. Schipper, M. Eijkemans, C. Welt, 2012, The Journal of clinical endocrinology and metabolism.

Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.

J. Visser, J. Laven, F. de Jong, 2011, Fertility and sterility.

Levels of Serum Anti–Müllerian Hormone, a Marker for Ovarian Reserve, in Women With Rheumatoid Arthritis

J. Laven, J. Hazes, J. Brouwer, 2013, Arthritis care & research.

Pregnancy outcome in female childhood cancer survivors.

M. Eijkemans, J. Laven, C. Hukkelhoven, 2010, Human reproduction.

Intra-ovarian Modification of FSH Action in the Human

I. Schipper, 1999 .

Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.

J. Visser, J. Laven, F. de Jong, 2008, Human reproduction.

The role of anti-Müllerian hormone in the classification of anovulatory infertility.

J. Visser, J. Laven, F. de Jong, 2015, European journal of obstetrics, gynecology, and reproductive biology.

Circulating immunoreactive and bioactive follicle stimulating hormone concentrations in anovulatory infertile women and during gonadotrophin induction of ovulation using a decremental dose regimen.

B. Fauser, K. Dahl, B. Schoot, 1996, Human reproduction.

Low levels of follicle-stimulating hormone receptor-activation inhibitors in serum and follicular fluid from normal controls and anovulatory patients with or without polycystic ovary syndrome.

B. Fauser, P. ten Hacken, F. Rommerts, 1997, The Journal of clinical endocrinology and metabolism.

Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.

S. Linn, C. Lambalk, T. Dahhan, 2017, Contemporary clinical trials.

Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?

B. Fauser, J. Visser, F. de Jong, 2008, Reproductive biomedicine online.

Pregnancy outcome of non-anonymous oocyte donation: a case-control study.

J. Laven, C. Hukkelhoven, M. V. D. van den Heuvel-Eibrink, 2014, European journal of obstetrics, gynecology, and reproductive biology.

Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies.

P. Sonneveld, P. Lugtenburg, J. Laven, 2008, Human reproduction.

Normal human follicle development: an evaluation of correlations with oestradiol, androstenedione and progesterone levels in individual follicles

B. Fauser, F. de Jong, T. Pache, 1996, Clinical endocrinology.

Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency

J. Visser, J. Laven, A. Themmen, 2012, Nature Reviews Endocrinology.

Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years.

B. Fauser, F. de Jong, I. Schipper, 1998, Human reproduction.

Premature and Early Menopause in Relation to Cardiovascular Disease

Y. Louwers, I. Schipper, 2020, Seminars in Reproductive Medicine.

The empty follicle syndrome is dead!

D. de Jong, E. J. V. van Santbrink, A. V. van Heusden, 2008, Fertility and sterility.

Limitations and pitfalls of antimüllerian hormone measurements.

J. Visser, J. Laven, A. Themmen, 2012, Fertility and sterility.

The role of anti-müllerian hormone in the classification of anovulation

J. Visser, J. Laven, O. Valkenburg, 2011 .

Genetic ancestry affects the phenotype of normogonadotropic anovulatory (WHOII) subfertility.

O. Lao, M. Kayser, J. Laven, 2011, The Journal of clinical endocrinology and metabolism.

Development of a human granulosa cell culture model with follicle stimulating hormone responsiveness.

P. Zarutskie, K. Dahl, I. Schipper, 1993, Human reproduction.